GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abcam PLC (MEX:ABCM) » Definitions » Stock Based Compensation

Abcam (MEX:ABCM) Stock Based Compensation : MXN398 Mil (TTM As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Abcam Stock Based Compensation?

Abcam's Stock Based Compensation for the six months ended in Jun. 2023 was MXN130 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Jun. 2023 was MXN398 Mil.


Abcam Stock Based Compensation Historical Data

The historical data trend for Abcam's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abcam Stock Based Compensation Chart

Abcam Annual Data
Trend Jun12 Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Dec22
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 90.26 88.84 158.25 268.67 553.30

Abcam Semi-Annual Data
Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Jun22 Dec22 Jun23
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 195.18 - 297.31 268.34 129.88

Abcam Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was MXN398 Mil.


Abcam Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of Abcam's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.


Abcam Business Description

Industry
Traded in Other Exchanges
N/A
Address
Discovery Drive, Cambridge Biomedical Campus, Cambridge, GBR, CB2 0AX
Abcam PLC is a biotechnology company that develops and provides antibodies to life science research and clinical communities. The company's products allow research into the role of signaling and regulatory molecules and proteins in biological pathways. Such research ultimately leads to treatments for diseases such as cancer and immune deficiency disorders. Abcam's focused on broadening its product range, improving speed to market, and accessing underpenetrated consumer groups in its markets. The company also selectively pursues partnerships and acquisitions.